Skip to main content
Noralixlabs
BLOG

Pharmaceutical development guides & checklists

Written for pharma professionals — technical, practical, and aligned to ICH expectations.

2026-04-24
ICH Q1A(R2) Stability Studies: Complete Guide for Pharmaceutical Companies
A practical, regulatory-aligned guide to ICH Q1A(R2) stability studies—study designs, storage conditions, data expectations for CTD dossiers, and how a CRO should execute stability programs.
Read article →
2026-04-18
CTD vs eCTD Dossier: Which Format Does Your Regulatory Filing Need?
Understand the practical difference between CTD and eCTD dossier formats, what regulators expect, and how to plan CTD/eCTD dossier preparation without rework across regions.
Read article →
2026-04-12
Tablet Formulation Development: Step-by-Step Process Guide
A practical guide to tablet formulation development—from preformulation and excipient selection to granulation, compression, dissolution, stability, and tech transfer-ready documentation.
Read article →
2026-04-06
How to Choose a Pharmaceutical CRO: 7 Critical Questions to Ask
A decision framework for selecting a pharmaceutical CRO in India—what to ask about ICH alignment, data integrity, method validation, stability execution, and dossier-ready deliverables.
Read article →
2026-03-30
Analytical Method Validation per ICH Q2(R1): Complete Checklist
A practical checklist for analytical method validation under ICH Q2(R1)—what to validate, how to justify acceptance criteria, and how to keep methods stability-indicating and dossier-ready.
Read article →
2026-03-22
Pharmaceutical Technology Transfer: Process, Documentation & Best Practices
A practical guide to pharmaceutical technology transfer—what to document, how to manage process knowledge, and how to move from development to commercial manufacturing with fewer deviations.
Read article →